Ascend Capital’s Zogenix, Inc. ZGNX Stock Holding History

Ascend Capital’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-199,784	Closed	-$8.83M	–	241
2018 Q2	$8.83M	Buy	199,784 +94,958	+91%	+$3.91M	0.42%	80
2018 Q1	$4.2M	Buy	104,826 +3,425	+3%	+$136K	0.17%	128
2017 Q4	$4.06M	Sell	101,401 -132,867	-57%	-$5.11M	0.15%	137
2017 Q3	$8.21M	Buy	+234,268	New	+$3.18M	0.31%	89

Other funds holding ZGNX

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ascend Capital's ZGNX Position: Q3 2018 in Review

Ascend Capital sold out of Zogenix, Inc. (ZGNX) in Q3 2018, closing a stake of 199,784 shares — an estimated $8.83M sold.

Ascend Capital first reported a position in ZGNX in Q3 2017 and held it in 4 quarters. The position peaked at $8.83M in Q2 2018. 170 funds tracked by Wall St. Rank hold ZGNX as of Q3 2018.

Ascend Capital reported no remaining Zogenix, Inc. position as of Q3 2018 after selling out during the quarter.
Ascend Capital sold 199,784 Zogenix, Inc. shares in Q3 2018, an estimated $8.83M.
Ascend Capital first reported a position in Zogenix, Inc. in Q3 2017 and held it in 4 quarters.
Ascend Capital's Zogenix, Inc. position peaked at $8.83M in Q2 2018.
170 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.